Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
Enjoying our new space!
We’re moving! Our new Washington, DC office is located on historic Pennsylvania Avenue. We hope you’ll come visit one of our 44 DC-based experts.
David, thanks for sharing! This is very insightful.
After all those years! Congrats!
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
We are one day away from the Third Annual GCR Pharmaceuticals conference. Mark Gidley from White & Case LLP and I are co-chairing a great event this year. I will be chairing a session focused on class certification in the UK and US, and will be joined by a great panel: Eric Hochstadt from Weil, Gotshal & Manges LLP, Kate Vernon from Quinn Emanuel, and Paul Harris QC from Monckton Chambers. We will discuss the recent Merricks v. MasterCard decision in the UK, and what that means for collective proceedings in the upcoming years, drawing lessons from recent developments in pharma class action in the US. In addition to this panel, this year's event will be keynoted by Fiona Scott Morton from Yale School of Management, former Deputy Assistant Attorney General for Economic Analysis. We will also feature a panel on health, data and privacy issues relating to pharma and competition, chaired by Mark, and another chaired by David Giardina from Sidley Austin LLP (including my colleague Sheng Li as a panelist) focused on biologic competition. While I will miss seeing everyone in person, the good thing about being virtual is that no matter where you are in the world, it's not too late to register and attend. I hope to see you in Zoom tomorrow!
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
I would encourage everyone to (virtually) attend. The GCR Pharma conference has been consistently excellent and thought-provoking, and we are putting on another excellent and thought-provoking conference this year. Come join us and our excellent speakers for a great event!
Join us on 11 March for the GCR Interactive: Pharmaceuticals conference chaired by David Blackburn, NERA Economic Consulting and Mark Gidley, White & Case LLP. They will be joined by corporate counsel, academics, enforcers and senior private practitioners working directly across current and future topics facing antitrust in the pharmaceutical industry. Register here: https://lnkd.in/dYhKf7p
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
Dan Werner, PhD, CPA provided pro bono consulting on damage issues relating to copyright and trademark rights for local non-profit Oakland Community Pools Project (OCPP). Compared to Dr. Werner’s reasonable license rate estimate, the court found the plaintiff’s original monetary demand “extortionate.” Read more about the case here:
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
👍👍
How do we rein in prescription drug costs without risking innovation? Associate Director Dr. Melissa Pittaoulis will provide insights on potential steps forward, particularly around the rising trend in value-based pricing of products, at this year’s Women Leaders in Life Sciences virtual conference on 18 November. Register here:
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
There's always lots to be learned about the economics of pharma and life sciences and no better place to learn it than from NERA's Life Sciences Practice. Omar is an amazing economist and I can't wait to learn more. I have read the article already, but I don't think it'll spoil the talk! ;) Register today!
Join Senior Consultant Dr. Omar Robles for an online discussion about the research, analysis, and findings in his recently published article, “What the Orange Book Reveals About Trends in Patent Density, Evergreening, and Exclusivity” on 20 August at 12:00 pm EDT. Space is limited to encourage a high level of interaction. Register now.
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
If you will be in New York on Thursday afternoon, please join us for a great set of speakers as we discuss recent events in the pharma industry and the implications for antitrust practitioners. Details below!
Director David Blackburn is the co-chair for the 2nd Annual Global Competition Review Live: Pharmaceuticals conference being held in New York on 27 February. We are proud to be a sponsor for this conference on antitrust litigation and the pharmaceutical industry. Learn more here: http://ow.ly/p6uH50yqvWa
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
Hey everyone, please come join us as we discuss some recent developments in the determination of reasonable royalties in patent cases, and we kick off NERA's webinar series.
What’s a reasonable opinion for a reasonable royalty? Hear from Director Dr. David Blackburn and attorney Cook Alciati in a NERA Insights Webinar on 20 February at 12:00 pm EST to learn what courts are saying about having a range of reasonable royalties versus identifying a single number. Register here: #NERAInsights
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
Come check it out!
Dr. David Blackburn and Dr. Rasmus Jørgensen will discuss key similarities and differences in the pricing of and market access to biosimilar and biologic drugs in the US and European regions in a webinar titled “The Economics of Biosimilars: Market Access, Pricing and Legal Considerations.” The webinar will be hosted on 10 December at 4:00 pm GMT. Register here: http://ow.ly/FjTY50xqT36
Intellectual Property and Antitrust Economist, Head of NERA's Life Sciences Practice
Dr. David Blackburn has been named Head of our Life Sciences Group. Dr. Blackburn’s expertise is in intellectual property, antitrust policy, and econometric analysis. He has worked in industries including medical devices, pharmaceuticals, entertainment, natural resources, and more.
Managing Director at NERA
2yLooking forward to seeing it first week of May!